A rational approach to benign prostatic hyperplasia evaluation: recent advances
Could self-management challenge pharmacotherapy as a long-term treatment for uncomplicated lower urinary tract symptoms?
Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents?
Who will benefit from combination therapy? The role of 5 alpha reductase inhibitors and alpha blockade: a reflection from MTOPS
High-power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate
Could the latest generation potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only?
Vaporization of the prostate
Can prostate stents be used to predict the outcome of transurethral resection of the prostate in the difficult cases?
Real life practice in the management of benign prostatic hyperplasia
Benign prostatic hyperplasia progression and its impact on treatment
Current World Literature